Structural Characterization and Cytotoxic Activity of Heteroleptic Copper (II) Complexes with L-Dipeptides and 5-NO2-Phenanthroline. Crystal Structure of [Cu(Phe- Ala)(5-NO2-Phen)].4H2O

Sebastián Iglesias1, Natalia Alvarez1, Gabriela Kramer M2, Torre MH1, Eduardo Kremer1, Javier Ellena3, Costa-Filho AJ4, Gianella Facchin1*

1Facultad de Qu?mica, General Flores 2124, Universidad de la Rep?blica, Montevideo, Uruguay

2Department of Biotechnology, Instituto de Higiene, Facultad de Medicina, Universidad de la Rep?blica (UdelaR), Av. Alfredo Navarro 3051, Montevideo, Uruguay

3Instituto de F?sica de S?o Carlos, Universidade de S?o Paulo, C.P. 369, 13560-970, S?o Carlos (SP), Brazil

4Faculdade de Filosofia, Ci?ncias e Letras de Ribeir?o Preto, Universidade de S?o Paulo, Av. Bandeirantes, 14040-901, Ribeir?o Preto (SP), Brasil

*Corresponding Author:
Gianella Facchin
Facultad de Qu?mica, General Flores 2124, Universidad de la Rep?blica, Montevideo, Uruguay
Tel: +59829249739
E-mail: [email protected]

Received Date: October 02, 2015, Accepted Date: October 28, 2015, Published Date:October 31, 2015

 
Visit for more related articles at Structural Chemistry & Crystallography Communication

Abstract

Objective: To prepare a new series of [Cu(L-dipeptide)(5-NO2-phen)] complexes and study the influence of the nitro group on the structure, DNA interaction and cytotoxic activity, aimed at finding new copper compounds with antitumor activity. Methodology and results: A series of mononuclear mixed ligand copper(II) complexes of the type [Cu(L-dipeptide)(5-NO2-phen)]·nH2O (where L-dipeptide: Ala-Phe, Phe-Ala, Phe-Val and Phe-Phe) were synthesized and characterized. The crystal structure of [Cu(Phe-Ala)(5-NO2-phen)]?4H2O was solved by X-Ray diffraction. The complexes present square-based pyramidal coordination geometry. UV-Vis spectroscopy results suggest that the coordination observed in solid state is maintained in solution. The complexes bind to isolated DNA, as studied by Circular Dichroism. Biological experiments showed that all the complexes induce cell death in HeLa (human cervical adenocarcinoma) and MDA-MB-231 (human metastatic breast adenocarcinoma) cell lines. Their cytotoxic activity is higher than that of the Cisplatin. Conclusions: Four new [Cu(L-dipeptide)(5-NO2-phen)]·nH2O were prepared, which present good cytotoxic activity. The introduction of the nitro group on the phen impaired DNA binding and cytotoxic activity.

Keywords

Copper complexes; Dipeptide; 5-NO2-phen; DRX; DNA interaction; Cytotoxic activity

Introduction

Coordination chemistry has provided medicine with drugs for clinical anticancer chemotherapy as well as a wider group of candidate compounds in different stages of research with promising activities. With the aim to obtain new antitumor metallo-drugs, complexes of several metals other than Pt are being studied [1]. In particular, under the hypothesis that endogenous metals may be less toxic than Pt, several copper complexes were studied looking for cytotoxic activity [2]. As a consequence, a variety of Cu-complexes were found to present high antitumor activity, as tested in vitro on several cancer cell lines, and a few of them on in vivo experiments [2,3]. One of the most relevant examples of active Cu-complexes are the coordination compounds Casiopeinas®, heteroleptic complexes containing an aromatic diimine and a coligand, two of which are already approved for clinical trials as antitumor drugs [4]. In this series of hetereolopetic compounds it was found that the aromatic diiminic ligand was the most influent ligand in relation to the biological activity, with subtle differences in its structure influencing strongly its activity [5,6].

Two heteroleptic Cu-5-NO2-1,10-phenanthroline complexes were reported to present potent antitumor activity in vitro, bringing the attention to this phen derivative as a ligand for further development of heteroleptic complexes with antitumor activity [7]. The 5-NO2-1,10-phenanthroline (5-NO2-phen) ligand presents different hydrophobicity and hydrogen bonding properties than the 1,10-phenanthroline (phen). It acts as an electron-attractor substituent, modifying the electronic properties of the molecule. These properties may influence their complexes reactivity, possibly showing different ability to bind to DNA than Cu-phen complexes [8-11]. As a result, their cytotoxic activity may be different. This difference possibly extends to heteroleptic 5-NO2- phen complexes.

Our research group has previously studied homoleptic Cu-Ldipeptide complexes [12-15] and heteroleptic Cu-L-dipeptidephen complexes [16]. While both present cytotoxic activity (IC50 Cu-L-dipeptide 20-50 μM, IC50 Cu-L-dipeptide-phen 1-20 μM on HeLa cells) phen containing complexes present higher activity showing the relevance of the phen ligand to the activity [16].

To move on with these studies, heteroleptic Cu(II) complexes with L-dipeptide and 5-NO2-1,10-phenanthroline were studied with the aim to evaluate the influence of the 5-NO2-phen moiety in their structure, DNA binding and cytotoxic activity. As coligands, four L-dipeptides were used, selecting those which presented good cytotoxic activity in the Cu-L-dipeptide-phen series (L-Ala-Phe, L-Phe-Ala, L-Phe-Val and L-Phe-Phe) [16]. In this context, this work reports the synthesis, characterization and DNA binding of four new [Cu(L-dipeptide)(5-NO2-1,10- phenanthroline)] compounds. In addition, their cytotoxic activity was evaluated in two cancer cell lines of human origin. To the best of our knowledge, no previous report on cytotoxic activity of copper complexes with dipeptides and 5-nitro-phen as ligands has been published to the date.

Materials and Methods

Reagents for synthesis and biochemical studies were used as commercially available: Copper salts (Fluka), L-dipeptides, 5-NO2- 1,10-phenanthroline (5-NO2-phen, SIGMA) and Calf thymus DNA (CT-DNA, SIGMA). Distilled water was used for all the experiments.

Synthesis of the complexes and analytical characterization

Ternary Cu-dipeptide-5-NO2-phen complexes (where L-dipetide: Ala-Phe, Phe-Ala, Phe-Val or Phe-Phe) were obtained as follows: 0.1 mmol of dipeptide were dissolved in 100 mL of warm water and 0.1 mmol of CuSO4·5H2O was added. The pH was adjusted to 7 with a 0.1 M NaOH solution. A solution of 0.1 mmol of 5- NO2-phen in 10 mL of ethanol was added. A blue solution was obtained. The compounds were isolated by evaporation at 50- 60° C, until blue crystals were formed. Yield 60-70%. To obtain single crystals, a small amount of the solution was allowed to slowly evaporate at room temperature. Blue crystals, suitable for X-ray diffraction, were only obtained for [Cu(Phe-Ala)(5- NO2- phen)]·4H2O.

Elemental analysis: [Cu(Ala-Phe)(5- NO2-phen)]·11H2O (C1) Calc. for C24H43CuN5O16: C, 39.97, N, 9.71, H, 6.01 Found: C, 40.32, N, 9.64, H, 5.61; [Cu(Phe-Ala)(5- NO2-phen)]·4H2O (C2) Calc. for C24H29CuN5O9: C, 48.44, N, 11.77, H, 4.91 Found: C, 48.09, N, 11.80, H, 4.90; [Cu(Phe-Val)(5- NO2-phen)]·4H2O (C3) Calc. for C26H33CuN5O9: C, 50.12, N, 11.24, H, 5.34 Found: C, 50.08, N, 11.27, H, 5.32; [Cu(Phe-Phe)(5- NO2-phen)]·3,5H2O (C4) Calc. for C30H32CuN5O8.5: C, 54.42, N, 10.58, H, 4.87 Found: C, 54.41, N, 10.64, H, 4.74.

Physical measurements

Chemical analyses for carbon, nitrogen, hydrogen and sulfur were performed with a Carlo Erba analyzer. Infrared spectra were recorded with a Bomen FT-IR spectrophotometer from 4000 to 400 cm−1 using KBr disks. UV–visible (UV–vis) spectra of the complexes in solution were carried out with a Milton Roy Spectronic 3000 spectrophotometer, using 1 cm path length quartz cells. Circular Dichroism spectra were recorded on a Jasco 720 instrument using 1 cm path length quartz cells.

Crystal structure determination of [Cu(Phe-Ala) (5-NO2-phen)]·4H2O, C2

Data for a suitable single crystal for complex C2 was collected at 293 [2] K on an Enraf-Nonius FR590 Kappa-CCD diffractometer using graphite monochromated MoKα radiation (0,71073 Å). Bruker AXS Collect software was used for data collection and the HKL Denzo-Scalepack program suite for data reduction. The structure was solved by direct methods using SIR-92 [17] and refined with SHELXL-2014 [18]. Multi-scan absorption correction was applied [19]. SHELXL-2014 and ORTEP-3 programs were used within the WinGX [20]. Molecular structure graphics were prepared using MERCURY program [21]. All non-hydrogen atoms were refined using anisotropic displacement parameters. Carbon bonded hydrogen atoms were stereochemically position and refined isotropically using the riding-model, thermal parameters set at 1.2 times the Uiso of the C atom they are bonded to Amino and water hydrogen atoms were found in the difference Fourier map, positionally fixed and their thermal parameters set to 1.2 times the Uiso of the nitrogen atom for the amine and 1.5 times the Uiso of the oxygen atom for the water molecules. Summary of the crystallographic data, experimental details and refinement results are listed in Table 1.

Empirical formula C24H29N5O9Cu
Formula weight 595.06
Temperature 293(2) K
Wave length 0.71073 Å
Crystal system Monoclinic
Space group C2
Unit cell dimensions
a=22.9400(8) Å a=90°
b=11.7710(5) Å b=112.860(2)°
c=10.6910(5) Å g=90°
Volume 2660.1(2) Å3
Z 4
Density (calculated) 1.486 Mg/m3
Absorption coefficient 0.882 mm-1
F(000) 1236
Crystal size 0.292 × 0.206 × 0.124 mm3
Theta range for data collection 3.122 to 26.716°
Index ranges -26<=h<=28 -14<=k<=14 -10<=l<=13
Reflections collected 10731
Independent reflections 5407 [R(int)=0.0274]
Completeness to theta=25.242° 99.7%
Absorption correction Multi-scan
Maximum and minimum transmission 0.896 and 0.804
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 5407 / 1 / 353
Goodness-of-fit on F2 1.037
Final R indices [I>2sigma(I)] R1=0.0367, wR2=0.0777
R indices (all data) R1=0.0502, wR2=0.0833
Absolute structure parameter -0.021(7)
Largest different peak and hole 0.347 and -0.343 e.Å-3

Table 1 Crystal data and structure refinement for C2.

Binding to DNA: CD studies

Absorption titration measurements were carried out on Calf Thymus-DNA in phosphate buffer solution (pH=7.4) as follows. To a 2.5 mL sample of 1.7 × 10-4 M CT-DNA 10 μL aliquots of the complexes 2.0 × 10-4 M in buffer were added. The CD spectra were registered after 15 m of incubation at room temperature.

Cytotoxicity studies

Cell lines were obtained from the American Type Culture Collection (ATCC): HeLa (CCL-2™, human cervical adenocarcinoma), MDAMB- 231 (HTB-22™, human metastatic breast adenocarcinoma). HeLa cells were grown in high glucose (4.5 g/L) Dulbecco's Modified Eagle Medium (DMEM) and MDA-MB-231 cells were grown in RPMI Medium both containing stable L-Glutamine and supplemented with 10% Fetal Bovine Serum (FBS, GE Healthcare). Cells were removed enzymatically from flasks using 0.01% Trypsin-EDTA solution. Cultured cells were incubated at 37°C on 5% CO2 atmosphere for 48 hours, containing solutions of the Cu complexes (final concentrations ranging from 1 to 50 μM). Cell viability in response to the complexes was determined by a colorimetric assay using Cell Counting Kit – 8 (Fulka) on 15.000 cells grown in 96-well plates. The kit utilizes a water-soluble tetrazolium salt that is reduced by dehydrogenases in cells to give a yellow colored product (formazan). The amount of the formazan dye generated by the activity of dehydrogenases in cells is directly proportional to the number of living cells. Absorbance of converted dye was measured at 450 nm using a micro plate reader. Cu-complexes solutions were prepared in 5% DMSO in water (due to poor solubility in water). The higher concentration of DMSO in culture medium was 0.5% (for the 100 μM test) and proved not to induce cytotoxicity. The IC50 was estimated from the dose-response curves, deviation between duplicates did not exceed 10%.

Results

Crystal structure

5-NO2-phen copper complexes have not been widely studied yet. There are only six X-ray crystal structures of copper complexes containing 5-NO2-phen reported to the date. None of them contains dipeptides as co-ligand [7,22-26]. The crystal structure of a new complex: [Cu(L-Phe-Ala)(5-NO2-phen)]·4H2O (C2) was obtained. The ortep type view of the compound with anisotropic displacement ellipsoids (50% probability) and numbering scheme is shown in Figure 1. The complex presents a coordination sphere where the copper ion is situated in a distorted squared pyramidal environment, equatorially coordinated to two N and one O atom from the dipeptide, and one N atom from the phen. The coordination sphere is completed by one N atom of the phen in the apical position. Table 2 shows bond distances and angles around the copper atom. The 5-NO2-phen ligand presents a usual bite distance (2.687 Å vs 2.64 mean distance for Cu(II)- 5-NO2- phen complexes according to the Cambridge Structural Data Base) and angle (77.20° vs 81.08° mean angle) and it is in a nearly orthogonal position with the Cu-peptide moiety. The distortion of the pyramidal environment was evaluated by means of τ factor which varies from 0 for perfect square pyramidal to 1 for trigonalbipyramid geometry [27]. τ=0.16, therefore the contribution of the trigonal-bipyramid geometry is 16%.

Selected Bond Length (Å) Cu1 N5 2.011(3)
Cu1 N4 1.891(4) Cu1 N2 2.025(4)
Cu1 O3 1.993(3) Cu1 N1 2.271(4)
Selected angles (°)
N4 Cu1 O3 83.39(13) N5 Cu1 N2 94.72(13)
N4 Cu1N5 83.40(13) N4 Cu1 N1 109.10(14)
O3 Cu1 N5 164.08(13) O3 Cu1 N1 96.02(13)
N4 Cu1 N2 173.55(18) N5Cu1 N1 96.68(14)
O3 Cu1 N2 97.43(14) N2 Cu1 N1 77.21(15)

Table 2 Selected bond lengths and angles.

structural-crystallography-ORTEP-representation

Figure 1: ORTEP representation of the asymmetric unit of [Cu(Phe-Ala)(5-NO2-phen)]·4H2O (C2). Water molecules were omitted for simplicity.

In order to determine the structural similarity between this 5-NO2- phen complex with its previously reported analogue containing phen [16] the crystal structures of [Cu(Phe-Ala)(5-NO2-phen) and [Cu(Phe-Ala)(phen)] were compared by means of the solid form module in the Mercury program. The restrictions applied to the search of similarity by the module were 20% distance and 10 degree angle tolerance. The comparison led up to a 97% similarity of the complexes’ powder diffraction patterns. When comparing one molecule of each there is a root mean square (rms) of 0.19 Å. Comparison of cell parameters are shown in Table 3 and the diagrams resulting from the comparison are shown in Figure 2. The compounds are isostructural. Moreover, the spatial disposition of atoms around the coordination center and throughout the crystal lattice was practically identical.

Compound Space group a b c α β γ
[Cu(phe-ala)(phen)]·4H2O C2 22.5305(4) Å 11.5646(2) Å 10.7493(2) Å 90° 116.108(1)° 90°
[Cu(phe-ala)(5-NO2-phen)]·4H2O C2 22.9400(8) Å 11.7710(5) Å 10.6910(5) Å 90° 112.860(2)° 90°

Table 3: Cell parameters comparison.

structural-crystallography-module-comparison

Figure 2: Diagram showing the results of the solid form module comparison tool for [Cu(Phe-Ala)(5-NO2- phen)] and [Cu(Phe-Ala)(phen)].

Infrared spectra of the complexes

The infrared spectra of the complexes present several commonfeatures. They are also similar to those of the Cu-dipeptide-phen complexes [16]. For instance, a broad, very strong peak around 1600 cm-1 attributed to ν(C=O)+ν(C-N)+νas(COO), indicative of the coordinated dipeptide moiety [12,13,28]. Absorption peaks corresponding to ring stretching frequencies of the 5-NO2- phen are slightly modified in relation to the free ligand and appear around 1515 cm-1 and 1420 cm-1, in agreement with the coordination of the 5-NO2-phen [29]. Other distinctive bands, like the ones due to C-H rocking in the 5-NO2-phen, appear from 1200 cm-1 to 720 cm-1, as shown in Table 4. Taking into account the similarity found in the infrared spectra of the complexes it can be assumed that the four studied complexes present a coordination similar to that observed for the [Cu(Phe-Ala)(5-NO2-phen)]·4H2O complex (C2).

Assignment n(C=O)+n(C-N)+ n(COO)as n(C=C) n(C=N) r(C-H) r(C-H) r (C-H) r(C-H)
5-NO2-phen --- 1518 1422 1148 1081 832 734
[Cu(ala-phe)( 5-NO2-phen)] 1589 1514 1420 1150 1079 836 734
[Cu(phe-ala)( 5-NO2-phen)] 1594 1514 1419 1152 1079 836 734
[Cu(phe-val)( 5-NO2-phen)] 1580 1514 1417 1155 1079 836 734
[Cu(phe-phe)( 5-NO2-phen)] 1591, 1576 1514 1417 1150 1079 836 734

Table 4 Wavenumber (cm-1) of representative absorption bands in the complexes and in free 5-NO2-phen, as well as their tentative assignment.

Characterization in aqueous solution: UV-visible

Table 5 presents the wavelength of the maxima of the visible spectra of the complexes. They present a broad peak around 625 nm with a shoulder at about 800 nm, characteristic of copper in penta coordinated environments [30]. The λmax values are similar to those of their [Cu(dipeptide)(phen)] analogs [16]. In an attempt to evaluate if the coordination observed in solid state is maintained in aqueous solution, UV-visible spectra of the complexes were analyzed using the work of Prenesti et al. who have previously developed visible spectra/structure correlations for Cu(II) complexes [31-33].

Compound λmax eM (M-1cm-1)
C1 621 132
C2 631 140
C3 623 141
C4 627 `145

Table 4: Wavelength of the maxima of the visible spectra of the complexes (λmax) and molar absorbance (εM).

The expected λmax for the observed coordination is 610-630 nm composed by: 580 nm (octahedral arrangement with an N3O equatorial coordination scheme) [31] plus 30-40 nm due to the presence of one N axially coordinated [33]. This value is in accordance with the observed values for this series of [Cu(dipeptide)(5-NO2-phen)] complexes. This analysis suggests that the same coordination observed in solid state is maintained for the major species in aqueous solution at the studied concentration (around 5 × 10-3 M). Similar results were previously reported for [Cu(Gly-Gly)(5-NO2-phen)] [34].

Binding to DNA: CD studies

The CD spectrum of CT-DNA was monitored alone, in the presence of 5-NO2-phen ligand and the complexes. Spectra for the ligand 5-NO2-phen is presented in Figure 3 (spectra for the other compounds can be found as supplementary material). Upon addition of the ligand 5-NO2-phen to CT-DNA, an intensity increase in the positive band of the spectrum is observed. Similar results are observed for all the complexes. These observation shows that 5-NO2-phen (and its complexes) binds to isolated DNA [35]. It also suggests an intercalative mode of binding of the 5-NO2-phen and its complexes to the DNA, as observed for other Cu-5-NO2-phen heteroleptic complexes [7]. The stacking of the complex molecules, possible through the 5-NO2-phen moiety, between the base pairs of DNA led to an enhancement in the positive band. These results are also similar to that obtained in the same conditions for the phen ligand. The extent of hyperchromism is qualitatively minor in the case of 5-NO2-phen and its complexes (around 20% for 5-NO2-phen and its complexes vs 50% for phen in the same experimental conditions) suggesting that the 5-nitro group impairs DNA binding. A similar behavior was also observed for a series of Ru mixed ligand complexes [36].

structural-crystallography-CD-spectra

Figure 3: CD spectra of DNA alone (red dotted line) and in the presence of 5-NO2-phen (black solid lines).

Cytotoxic activity

Table 6 presents the IC50 values for the studied complexes. All of them present higher cytotoxic activity (lower IC50) on HeLa and MDA-MB-231 cells than Cisplatin. [Cu(dipeptide)(5-NO2- phen)] complexes show similar activity to [Cu(5-NO2-phen)2Cl2. Compared with their phen analogs, the 5-NO2-phen complexes present lower activity (for instance, [Cu(ala-phe)(phen)] presents an IC50 2 μM on HeLa cells [16]. This tendency was previously observed in the Casiopeinas series, where complexes containing 5-NO2-phen had larger IC50 than their counterparts with phen [6], showing the relevance of the phen moiety on the activity of the complexes. This reduction of the cytotoxic activity is possibly related to the fact that the nitro group impairs DNA binding. The electron-attractor effect of the nitro substituent on the phen can also influence the reactivity of the Cu center in the complexes and therefore their activity. The activity of the complexes makes them good candidates to perform in vivo antitumor tests comparing they tissue distribution, which may be different from that of the related phen complexes.

Compound IC50 (mM) Hela IC50 (mM) MDA MB 231
[Cu(Ala-Phe)(5-NO2-phen)] 13 4.0
[Cu(Phe-Ala)(5-NO2-phen)] >20 8.4
[Cu(Phe-Val)(5-NO2-phen)] 14 4.8
[Cu(Phe-Phe)(5-NO2-phen)] >20 9.3
[Cu(5-NO2-phen)2]Cl2 16 5.8
Cisplatin 50 30

Table 6: Cytotoxic activity (expressed by IC50) of the studied complexes against HeLa and MDA-MB-23 cell lines.

Conclusions

Four new complexes were synthesized and characterized. They present square-based pyramidal coordination geometry with a dipeptide and a 5-NO2-phen coordinated to the Cu(II) center, perpendicular to each other. UV-vis spectra suggest no change in coordination upon dissolution. The complexes bind to isolated DNA, possibly by intercalation. The extent of binding is lower than that observed for Cu-dipeptide-phen complexes. The complexes present cytotoxic activity against the studied cell lines, higher than Cisplatin. The introduction of the nitro group in the phen reduces the cytotoxic activity of the complexes.

Acknowledgements

The authors thank CSIC and PEDECIBA Química and Biología (Uruguay); CNPq and FAPESP (Brazil) and CAPES/UdelaR (Brazil- Ururguay bilateral research grant) for financial support.

Supplementary data

CCDC 1055554 contains the supplementary crystallographic data for C2. This data can be obtained free of charge via https:// summary.ccdc.cam.ac.uk/structure-summary-form, or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK, Fax: (+44) 1223-336-033. CD spectra of DNA alone and in the presence of the studied compounds (Figure S1 – S5).

References

Select your language of interest to view the total content in your interested language

Viewing options

Post your comment

Share This Article

Recommended Conferences

Flyer image
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh